P. Ruggenenti, M. Noris, and G. Remuzzi, Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura, Kidney International, vol.60, issue.3, p.83146, 2001.
DOI : 10.1046/j.1523-1755.2001.060003831.x

URL : http://doi.org/10.1046/j.1523-1755.2001.060003831.x

L. Wood and P. Jacobs, The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin, and complement levels, Journal of Clinical Apheresis, vol.24, issue.2, p.1248, 1986.
DOI : 10.1002/jca.2920030209

P. Lara, T. Coe, H. Zhou, L. Fernando, P. Holland et al., Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, The American Journal of Medicine, vol.107, issue.6, p.5739, 1999.
DOI : 10.1016/S0002-9343(99)00286-7

C. Lockwood, A. Rees, T. Pearson, D. Evans, D. Peters et al., IMMUNOSUPPRESSION AND PLASMA-EXCHANGE IN THE TREATMENT OF GOODPASTURE'S SYNDROME, The Lancet, vol.307, issue.7962, p.7115, 1976.
DOI : 10.1016/S0140-6736(76)93089-0

J. Schwartz, J. Winters, A. Padmanabhan, R. Balogun, M. Delaney et al., Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue, Journal of Clinical Apheresis, vol.28, issue.3, p.145284, 2013.
DOI : 10.1002/jca.21276

S. Mcguckin, J. Westwood, H. Webster, D. Collier, D. Leverett et al., Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience, Vox Sanguinis, vol.20, issue.2, p.1616, 2014.
DOI : 10.1111/vox.12090

D. Shemin, D. Briggs, and M. Greenan, Complications of therapeutic plasma exchange: A prospective study of 1,727 procedures, Journal of Clinical Apheresis, vol.46, issue.5, p.2706, 2007.
DOI : 10.1002/jca.20143

M. Rizvi, S. Vesely, J. George, L. Chandler, D. Duvall et al., Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome, Transfusion, vol.13, issue.8, p.896901, 2000.
DOI : 10.1056/NEJM199812313392708

B. Mcleod, I. Sniecinski, D. Ciavarella, H. Owen, T. Price et al., Frequency of immediate adverse effects associated with therapeutic apheresis, Transfusion, vol.16, issue.3, p.2828, 1999.
DOI : 10.1046/j.1537-2995.1999.39399219285.x

N. Basic-jukic, P. Kes, S. Glavas-boras, B. Brunetta, L. Bubic-filipi et al., Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial Off Peer-Rev, oct, vol.9, issue.5, p.3915, 2005.

J. Korach, P. Berger, C. Giraud, L. Perff-desman, C. Chillet et al., Role of replacement fluids in the immediate complications of plasma exchange. French Registry Cooperative Group, Intensive Care Med. mai, vol.24, issue.5, p.4528, 1998.

R. Mcclain, D. Terrell, S. Vesely, and J. George, Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014, Transfusion, vol.54, issue.12, p.32579, 2014.
DOI : 10.1111/trf.12917

C. Bramlage, K. Schröder, P. Bramlage, K. Ahrens, A. Zapf et al., Predictors of complications in therapeutic plasma exchange, Journal of Clinical Apheresis, vol.335, issue.6, p.22531, 2009.
DOI : 10.1002/jca.20217

M. Pruijm, A. Cherpillod, B. Vogt, and M. Burnier, Plasmapheresis: technique, complications and indications. Rev Médicale Suisse. 5 mars, pp.5812-588, 2008.

J. Korach, H??maph??r??se th??rapeutique adulte et p??diatrique, R??animation, vol.14, issue.7, pp.641-650, 2005.
DOI : 10.1016/j.reaurg.2005.10.002

P. Charbonneau, Plasma exchange Ann Fr Anesthèsie Rèanimation, p.28491, 1984.

F. Lefrère, Therapeutic plasma exchange : methods and indications, Hématologie, vol.18, issue.1, pp.51-59, 2012.

J. Timsit, J. Farkas, J. Boyer, J. Martin, B. Misset et al., Central Vein Catheter-Related Thrombosis in Intensive Care Patients, Chest, vol.114, issue.1, p.20713, 1998.
DOI : 10.1378/chest.114.1.207

M. Kamochi, K. Aibara, K. Nakata, M. Murakami, K. Nandate et al., Profound ionized hypomagnesemia induced by therapeutic plasma exchange in liver failure patients, Transfusion, vol.61, issue.12, p.1598602, 2002.
DOI : 10.1038/sj.bmt.1702472

F. Van-der-meché and P. Schmitz, A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group, N Engl J Med. 23 avr, vol.326, issue.17, p.11239, 1992.

A. Hahn, C. Bolton, N. Pillay, C. Chalk, T. Benstead et al., Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, shamcontrolled , cross-over study, Brain J Neurol. août, vol.119, p.105566, 1996.

P. Dyck, J. Daube, O. Brien, P. Pineda, A. Low et al., Plasma Exchange in Chronic Inflammatory Demyelinating Polyradiculoneuropathy, New England Journal of Medicine, vol.314, issue.8, p.4615, 1986.
DOI : 10.1056/NEJM198602203140801

P. Dyck, P. Low, A. Windebank, S. Jaradeh, S. Gosselin et al., Plasma Exchange in Polyneuropathy Associated with Monoclonal Gammopathy of Undetermined Significance, New England Journal of Medicine, vol.325, issue.21, p.14826, 1991.
DOI : 10.1056/NEJM199111213252105

I. Cortese, V. Chaudhry, Y. So, F. Cantor, D. Cornblath et al., Evidence-based guideline update: Plasmapheresis in neurologic disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, vol.76, issue.3, p.294300, 2011.
DOI : 10.1212/WNL.0b013e318207b1f6

B. Guidet, P. Korach, . Berger, C. Le-groupe, and . Français, Échanges plasmatiques en réanimation. Conférences d'actualisation, pp.533-575, 1996.

P. Goti, A. Spinelli, G. Marconi, R. Duranti, F. Gigliotti et al., Comparative effects of plasma exchange and pyridostigmine on respiratory muscle strength and breathing pattern in patients with myasthenia gravis., Thorax, vol.50, issue.10, p.10806, 1995.
DOI : 10.1136/thx.50.10.1080

A. Mandawat, H. Kaminski, G. Cutter, B. Katirji, and A. Alshekhlee, Comparative analysis of therapeutic options used for myasthenia gravis, Annals of Neurology, vol.7, issue.1, p.797805, 2010.
DOI : 10.1002/ana.22139

W. Köhler, C. Bucka, and R. Klingel, A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis, Journal of Clinical Apheresis, vol.33, issue.6, p.34755, 2011.
DOI : 10.1002/jca.20317

B. Sarkar, P. Sengupta, and U. Sarkar, Surgical outcome in thymic tumors with myasthenia gravis after plasmapheresis - a comparative study, Interactive CardioVascular and Thoracic Surgery, vol.7, issue.6, p.100710, 2008.
DOI : 10.1510/icvts.2007.170894

T. Nagayasu, T. Yamayoshi, K. Matsumoto, N. Ide, S. Hashizume et al., Beneficial effects of plasmapheresis before thymectomy on the outcome in myasthenia gravis, The Japanese Journal of Thoracic and Cardiovascular Surgery, vol.11, issue.1, p.27, 2005.
DOI : 10.1007/s11748-005-1001-y

H. Weiner, P. Dau, B. Khatri, J. Petajan, G. Birnbaum et al., Doubleblind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis, Neurology. sept, vol.39, issue.9, p.11439, 1989.

B. Weinshenker, O. Brien, P. Petterson, T. Noseworthy, J. Lucchinetti et al., A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease, Annals of Neurology, vol.44, issue.6, p.87886, 1999.
DOI : 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q

M. Keegan, A. Pineda, R. Mcclelland, C. Darby, M. Rodriguez et al., Plasma exchange for severe attacks of CNS demyelination: Predictors of response, Neurology, vol.58, issue.1, p.1436, 2002.
DOI : 10.1212/WNL.58.1.143

M. Bonnan, H. Brasme, M. Diaby, M. Vlaicu, L. Guern et al., [Severe bouts of neuromyelitis optica: dramatic improvement after plasma exchanges], Rev Neurol, vol.165, issue.5, p.47981, 2009.

P. Schwab and J. Fahey, Treatment of Waldenstr??m's Macroglobulinemia by Plasmapheresis, New England Journal of Medicine, vol.263, issue.12, p.5749, 1960.
DOI : 10.1056/NEJM196009222631202

A. Solomon and J. Fahey, Plasmapheresis therapy in macroglobulinemia, Ann Intern Med. mai, vol.58, p.789800, 1963.

M. Ballestri, F. Ferrari, R. Magistroni, M. Mariano, G. Ceccherelli et al., Plasma exchange in acute and chronic hyperviscosity syndrome: a rheological approach and guidelines study, Ann DellIstituto Super Sanità, vol.43, issue.2, p.1715, 2007.

M. Stone and S. Bogen, Evidence-based focused review of management of hyperviscosity syndrome, Blood, vol.119, issue.10, p.22058, 2012.
DOI : 10.1182/blood-2011-04-347690

J. Mehta and S. Singhal, Hyperviscosity syndrome in plasma cell dyscrasias, Semin Thromb Hemost. oct, vol.29, issue.5, p.46771, 2003.

S. Ansell, R. Kyle, C. Reeder, R. Fonseca, J. Mikhael et al., Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines, Mayo Clin Proc. sept, vol.85, issue.9, p.82433, 2010.

N. Leung, M. Gertz, S. Zeldenrust, S. Rajkumar, A. Dispenzieri et al., Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains, Kidney International, vol.73, issue.11, p.12828, 2008.
DOI : 10.1038/ki.2008.108

J. Capra and H. Kunkel, Aggregation of gamma-G3 proteins: relevance to the hyperviscosity syndrome, J Clin Invest. mars, vol.49, issue.3, p.61021, 1970.

R. Pope, M. Mannik, B. Gilliland, and D. Teller, The hyperviscosity syndrome in rheumatoid arthritis due to intermediate complexes formed by self-association of IgGrheumatoid factors, Arthritis Rheum. avr, vol.18, issue.2, p.97106, 1975.

P. Coppo and A. Veyradier, Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura. Presse Médicale Paris Fr 1983, mars, vol.41, p.16376, 2012.

S. Nathanson, T. Kwon, M. Elmaleh, M. Charbit, E. Launay et al., Acute Neurological Involvement in Diarrhea-Associated Hemolytic Uremic Syndrome, Clinical Journal of the American Society of Nephrology, vol.5, issue.7, p.121828, 2010.
DOI : 10.2215/CJN.08921209

E. Colic, H. Dieperink, K. Titlestad, and M. Tepel, Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study, The Lancet, vol.378, issue.9796, p.108993, 2011.
DOI : 10.1016/S0140-6736(11)61145-8

C. Lefaucheur, D. Nochy, J. Andrade, J. Verine, C. Gautreau et al., Comparison of Combination Plasmapheresis/IVIg/Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection, American Journal of Transplantation, vol.359, issue.5 Pt 1, p.1099107, 2009.
DOI : 10.1111/j.1600-6143.2009.02591.x

N. White, S. Greenstein, A. Cantafio, R. Schechner, D. Glicklich et al., Successful Rescue Therapy with Plasmapheresis and Intravenous Immunoglobulin for Acute Humoral Renal Transplant Rejection, Transplantation, vol.78, issue.5, p.7724, 2004.
DOI : 10.1097/01.TP.0000128194.55934.48

P. Rocha, D. Butterly, A. Greenberg, D. Reddan, J. Tuttle-newhall et al., Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection, Transplantation. 15 mai, vol.75, issue.9, p.14905, 2003.

R. Lehrich, P. Rocha, N. Reinsmoen, A. Greenberg, D. Butterly et al., Intravenous Immunoglobulin and Plasmapheresis in Acute Humoral Rejection: Experience in Renal Allograft Transplantation, Human Immunology, vol.66, issue.4, p.3508, 2005.
DOI : 10.1016/j.humimm.2005.01.028

M. Stegall, J. Gloor, J. Winters, S. Moore, and S. Degoey, A Comparison of Plasmapheresis Versus High-Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody, American Journal of Transplantation, vol.3, issue.5, p.34651, 2006.
DOI : 10.1097/01.TP.0000112934.12622.2B

R. Montgomery, B. Lonze, K. King, E. Kraus, L. Kucirka et al., Desensitization in HLA-Incompatible Kidney Recipients and Survival, New England Journal of Medicine, vol.365, issue.4, p.31826, 2011.
DOI : 10.1056/NEJMoa1012376

J. Gloor, D. Lager, S. Moore, A. Pineda, M. Fidler et al., ABOincompatible kidney transplantation using both A2 and non-A2 living donors, Transplantation. 15 avr, vol.75, issue.7, p.9717, 2003.
DOI : 10.1097/01.tp.0000058226.39732.32

K. Tanabe, K. Takahashi, K. Sonda, T. Tokumoto, N. Ishikawa et al., Long-term results of ABO-incompatible living kidney transplantation: a single-center experience, Transplantation. 27 janv, vol.65, issue.2, p.2248, 1998.

J. Winters, J. Gloor, A. Pineda, M. Stegall, and S. Moore, Plasma exchange conditioning for ABO-incompatible renal transplantation, Journal of Clinical Apheresis, vol.341, issue.2, p.7985, 2004.
DOI : 10.1002/jca.20002

M. Jin, J. Cho, O. Kwon, K. Hong, J. Choi et al., Successful Kidney Transplantation After Desensitization Using Plasmapheresis, Low-Dose Intravenous Immunoglobulin, and Rituximab in Highly Sensitized Patients: A Single-Center Experience, Transplantation Proceedings, vol.44, issue.1, 2003.
DOI : 10.1016/j.transproceed.2011.11.040

R. Higgins, D. Bevan, B. Carey, C. Lea, M. Fallon et al., Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation, The Lancet, vol.348, issue.9036, p.120811, 1996.
DOI : 10.1016/S0140-6736(96)03452-6

J. Levy, A. Turner, A. Rees, and C. Pusey, Long-Term Outcome of Anti???Glomerular Basement Membrane Antibody Disease Treated with Plasma Exchange and Immunosuppression, Annals of Internal Medicine, vol.134, issue.11, p.103342, 2001.
DOI : 10.7326/0003-4819-134-11-200106050-00009

P. Klemmer, W. Chalermskulrat, M. Reif, S. Hogan, D. Henke et al., Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis, American Journal of Kidney Diseases, vol.42, issue.6, p.114953, 2003.
DOI : 10.1053/j.ajkd.2003.08.015

W. Glöckner, H. Sieberth, H. Wichmann, E. Backes, R. Bambauer et al., Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study, Clin Nephrol. janv, vol.29, issue.1, p.18, 1988.

E. Cole, D. Cattran, A. Magil, C. Greenwood, D. Churchill et al., A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group, Am J Kidney Dis Off J Natl Kidney Found. sept, vol.20, issue.3, p.2619, 1992.

C. Pusey, A. Rees, D. Evans, D. Peters, and C. Lockwood, Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies, Kidney International, vol.40, issue.4, p.75763, 1991.
DOI : 10.1038/ki.1991.272

G. Rifle and E. Dechelette, Treatment of rapidly progressive glomerulonephritis by plasma exchange and methylprednisolone pulses. A prospective randomized trial of cyclophosphamide. Interim analysis. The French Cooperative Group, Prog Clin Biol Res, vol.337, p.2637, 1990.

L. Mouthon, A. Millet, A. Régent, M. Pederzoli-ribeil, and V. Witko-sarsat, Pathophysiology of ANCA-associated vasculitides]. Presse Médicale Paris Fr, oct, vol.41, issue.10, p.9961003, 1983.

D. Jayne, G. Gaskin, N. Rasmussen, D. Abramowicz, F. Ferrario et al., Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis, Journal of the American Society of Nephrology, vol.18, issue.7, p.21808, 2007.
DOI : 10.1681/ASN.2007010090

M. Walsh, F. Catapano, W. Szpirt, K. Thorlund, A. Bruchfeld et al., Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis, American Journal of Kidney Diseases, vol.57, issue.4, p.56674, 2011.
DOI : 10.1053/j.ajkd.2010.10.049

I. Uthman, A. Shamseddine, and A. Taher, The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndrome, Transfusion and Apheresis Science, vol.33, issue.1, p.117, 2005.
DOI : 10.1016/j.transci.2004.10.025

E. Lewis, L. Hunsicker, S. Lan, R. Rohde, and J. Lachin, A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group, N Engl J Med. 21 mai, vol.326, issue.21, p.13739, 1992.

. Guillevin, ??changes plasmatiques dans les maladies syst??miques??: leur place actuellePlasma exchange: their current place in the treatment of systemic diseases., R??animation, vol.11, issue.5, pp.359-65, 2002.
DOI : 10.1016/S1624-0693(02)00256-6

M. Bortolati, P. Marson, F. Fabris, V. Pengo, M. Facchinetti et al., Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: report of four cases and review of the literature, Autoimmunity Reviews, vol.8, issue.4, p.297301, 2009.
DOI : 10.1016/j.autrev.2008.09.002

N. Costedoat-chalumeau, L. Arnaud, D. Saadoun, J. Chastre, G. Leroux et al., Catastrophic antiphospholipid syndrome]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, avr, vol.33, issue.4, p.1949, 2012.

. Guillevin, ??changes plasmatiques dans les maladies syst??miques??: leur place actuellePlasma exchange: their current place in the treatment of systemic diseases., R??animation, vol.11, issue.5, pp.359-65, 2002.
DOI : 10.1016/S1624-0693(02)00256-6

C. Pusey and J. Levy, Plasmapheresis in Immunologic Renal Disease, Blood Purification, vol.33, issue.1-3, 1908.
DOI : 10.1159/000334155

L. Guillevin, F. Lhote, M. Gayraud, P. Cohen, B. Jarrousse et al., Prognostic Factors in Polyarteritis Nodosa and Churg-Strauss Syndrome A Prospective Study in 342 Patients, Medicine, vol.75, issue.1, p.1728, 1996.
DOI : 10.1097/00005792-199601000-00003

P. Chérin and S. Herson, Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins

S. Herson, C. Lok, J. Roujeau, A. Coutellier, S. Etienne et al., Plasma exchange in dermatomyositis and polymyositis. Retrospective study of 38 cases of plasma exchange], Ann Médecine Interne, vol.140, issue.6, p.4535, 1989.

L. Guern, V. Guillevin, and L. , Therapeutic apheresis for myositises, Transfusion and Apheresis Science, vol.36, issue.2, p.16972, 2007.
DOI : 10.1016/j.transci.2007.01.008

F. Miller, S. Leitman, M. Cronin, J. Hicks, R. Leff et al., Controlled Trial of Plasma Exchange and Leukapheresis in Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.326, issue.21, p.13804, 1992.
DOI : 10.1056/NEJM199205213262102

W. Aengevaeren, A. Kroon, A. Stalenhoef, G. Uijen, and T. Van-der-werf, Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS), J Am Coll Cardiol. déc, vol.28, issue.7, p.1696704, 1996.

S. Bohl, U. Kassner, R. Eckardt, W. Utz, J. Mueller-nordhorn et al., Single Lipoprotein Apheresis Session Improves Cardiac Microvascular Function in Patients With Elevated Lipoprotein(a): Detection by Stress/Rest Perfusion Magnetic Resonance Imaging, Therapeutic Apheresis and Dialysis, vol.71, issue.2, p.12937, 2009.
DOI : 10.1111/j.1744-9987.2009.00667.x

T. Bosch and C. Keller, Clinical Effects of Direct Adsorption of Lipoprotein Apheresis: Beyond Cholesterol Reduction, Therapeutic Apheresis and Dialysis, vol.6, issue.3, p.3414, 2003.
DOI : 10.1002/jca.10010

T. Agishi, S. Naganuma, S. Nakasato, K. Kitajima, K. Ota et al., Treatment of Arteriosclerotic Obstruction by LDL Adsorption, Angiology, vol.44, issue.3, p.2227, 1993.
DOI : 10.1177/000331979304400308

T. Bosch, Direct Adsorption of Lipoproteins from Whole Blood by DALI Apheresis: Technique and Effects, Therapeutic Apheresis and Dialysis, vol.21, issue.4, p.23943, 2001.
DOI : 10.1046/j.1365-2362.1996.2320587.x

E. Burgstaler and A. Pineda, Plasma exchange versus an affinity column for cholesterol reduction, Journal of Clinical Apheresis, vol.29, issue.2, p.6974, 1992.
DOI : 10.1002/jca.2920070206

U. Julius, K. Parhofer, A. Heibges, S. Kurz, R. Klingel et al., Dextran-sulfateadsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipidapheresis--comparison of performance characteristics with DALI and Lipidfiltration, J Clin Apheresis, vol.22, issue.4, p.21523, 2007.

F. Dairou, J. Rottembourg, J. Truffert, U. Assogba, E. Bruckert et al., Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques, Beitr Zur Infusionstherapie Contrib Infus Ther, vol.23, p.1529, 1988.

N. Ewald and H. Kloer, Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis, Clinical Research in Cardiology Supplements, vol.56, issue.3, p.315, 2012.
DOI : 10.1007/s11789-012-0042-x

D. Betteridge, M. Bakowski, K. Taylor, J. Reckless, S. De-silva et al., TREATMENT OF SEVERE DIABETIC HYPERTRIGLYCERID??MIA BY PLASMA EXCHANGE, The Lancet, vol.311, issue.8078, p.1368, 1978.
DOI : 10.1016/S0140-6736(78)92450-9

A. Lennertz, K. Parhofer, W. Samtleben, and T. Bosch, Therapeutic Plasma Exchange in Patients with Chylomicronemia Syndrome Complicated by Acute Pancreatitis, Therapeutic Apheresis and Dialysis, vol.21, issue.3, p.22733, 1999.
DOI : 10.1001/jama.265.7.904

J. Yeh, M. Lee, and H. Chiu, Plasmapheresis for severe lipemia: Comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants, Journal of Clinical Apheresis, vol.151, issue.1, p.326, 2003.
DOI : 10.1002/jca.10047

M. Crespo-leiro, A. Veiga-barreiro, N. Doménech, M. Paniagua, P. Piñón et al., Humoral Heart Rejection (Severe Allograft Dysfunction with no Signs of Cellular Rejection or Ischemia): Incidence, Management, and the Value of C4d for Diagnosis, American Journal of Transplantation, vol.12, issue.7, p.25604, 2005.
DOI : 10.1097/00007890-199909270-00024

O. Grauhan, C. Knosalla, R. Ewert, M. Hummel, M. Loebe et al., Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation, The Journal of Heart and Lung Transplantation, vol.20, issue.3, p.31621, 2001.
DOI : 10.1016/S1053-2498(00)00211-4

S. Leech, M. Lopez-cepero, W. Lefor, L. Dichiara, M. Weston et al., Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin, Clinical Transplantation, vol.100, issue.4, p.47684, 2006.
DOI : 10.1097/00007890-199609150-00027

M. Colvin, J. Cook, P. Chang, G. Francis, D. Hsu et al., Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management, Circulation, vol.131, issue.18, 2015.
DOI : 10.1161/CIR.0000000000000093

D. Couriel and R. Weinstein, Complications of therapeutic plasma exchange: A recent assessment, Journal of Clinical Apheresis, vol.16, issue.1, p.15, 1994.
DOI : 10.1002/jca.2920090102

G. Rock, K. Shumak, N. Buskard, V. Blanchette, J. Kelton et al., Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group, N Engl J Med. 8 août, vol.325, issue.6, p.3937, 1991.

S. Brunskill, A. Tusold, S. Benjamin, S. Stanworth, and M. Murphy, A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura, Transfusion Medicine, vol.16, issue.Suppl. 95, p.1735, 2007.
DOI : 10.1111/j.1365-3148.2006.00720.x

D. Jayne, N. Rasmussen, K. Andrassy, P. Bacon, J. Tervaert et al., A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies, New England Journal of Medicine, vol.349, issue.1, p.3644, 2003.
DOI : 10.1056/NEJMoa020286

C. Mukhtyar, L. Guillevin, M. Cid, B. Dasgupta, K. Groot et al., EULAR recommendations for the management of primary small and medium vessel vasculitis, Annals of the Rheumatic Diseases, vol.68, issue.3
DOI : 10.1136/ard.2008.088096

D. Petitpas, S. Ould-zein, and J. Korach, What are the indications for plasma exchanges in autoimmune diseases?: The registry of the Soci??t?? Fran??aise d???H??maph??r??se, Transfusion and Apheresis Science, vol.36, issue.2, p.1737, 2007.
DOI : 10.1016/j.transci.2007.01.007

Z. Al-nouri, J. Reese, D. Terrell, S. Vesely, and J. George, Drug-induced thrombotic microangiopathy: a systematic review of published reports, Blood, vol.125, issue.4, p.6168, 2015.
DOI : 10.1182/blood-2014-11-611335

J. Reese, D. Bougie, B. Curtis, D. Terrell, S. Vesely et al., Drug-induced thrombotic microangiopathy: Experience of the Oklahoma registry and the BloodCenter of Wisconsin, American Journal of Hematology, vol.63, issue.5, 2015.
DOI : 10.1002/ajh.23960

J. Chapin, T. Shore, P. Forsberg, G. Desman, K. Van-besien et al., Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments, Clin Adv Hematol Oncol HO. sept, vol.12, issue.9, p.56573, 2014.

J. George, D. Terrell, S. Vesely, K. Hovinga, J. Lämmle et al., Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Médicale Paris Fr 1983, mars, vol.41, issue.3 2, p.17788, 2012.

P. Kuczia, B. Soko?owska, W. Szczeklik, M. Kózka, J. Sznajd et al., Effective application of therapeutic plasma exchange in a case of acute dermatomyositis]. Przeglad Lek, p.12301, 2012.

J. Korach, L. Guillevin, D. Petitpas, P. Berger, and P. Chillet, Apheresis registry in France: indications, techniques, and complications. French Registry Study Group, Ther Apher Off J Int Soc Apher Jpn Soc Apher. juin, vol.4, issue.3, p.20710, 2000.

R. Norda, O. Berséus, and B. Stegmayr, Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry, Transfusion and Apheresis Science, vol.25, issue.1, p.3341, 2001.
DOI : 10.1016/S1473-0502(01)00079-9

R. Norda, B. Stegmayr, . Swedish-apheresis, and . Group, Therapeutic apheresis in Sweden: update of epidemiology and adverse events, Transfusion and Apheresis Science, vol.29, issue.2, p.15966, 2003.
DOI : 10.1016/S1473-0502(03)00121-6

J. Córdoba, C. Larrarte, and M. Medina, Experience in therapeutic plasma exchange by membrane filtration at an academic center in Colombia: Registry of the first 500 sessions, Journal of Clinical Apheresis, vol.30, issue.6, 2015.
DOI : 10.1002/jca.21391

U. Salge-bartels, S. Breitner-ruddock, A. Hunfeld, R. Seitz, and M. Heiden, Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe?, Transfusion Medicine, vol.43, issue.4, p.26675, 2006.
DOI : 10.1046/j.1365-2141.2003.04360.x

R. Flamholz, H. Jeon, J. Baron, and B. Baron, Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: Is its decreased protein S activity clinically related to their development of deep venous thromboses?, Journal of Clinical Apheresis, vol.30, issue.3, p.16972, 2000.
DOI : 10.1002/1098-1101(2000)15:3<169::AID-JCA2>3.0.CO;2-R

K. Polderman and A. Girbes, Central venous catheter use, Intensive Care Medicine, vol.28, issue.1, p.117, 2002.
DOI : 10.1007/s00134-001-1154-9

K. Polderman and A. Girbes, Central venous catheter use, Intensive Care Medicine, vol.28, issue.1, p.1828, 2002.
DOI : 10.1007/s00134-001-1156-7

M. Michel and B. Godeau, Complications infectieuses des maladies systémiques/ Infections in systemic rheumatic diseases, pp.621-628622, 2005.

B. Terrier, E. Krastinova, I. Marie, D. Launay, A. Lacraz et al., Management of non infectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey, Blood, vol.119, 2012.

D. Lacaille, D. Guh, M. Abrahamowicz, A. Anis, and J. Esdaile, Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.44, issue.8, pp.1074-1081, 2008.
DOI : 10.1002/art.23913

B. Pryor, S. Bologna, and L. Kahl, Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus, Arthritis & Rheumatism, vol.32, issue.9, p.147582, 1996.
DOI : 10.1002/art.1780390906

J. Widdifield, S. Bernatsky, J. Paterson, N. Gunraj, J. Thorne et al., Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis, Arthritis Care & Research, vol.63, issue.Suppl, p.35361, 2013.
DOI : 10.1002/acr.21812

H. Dussauze, I. Bourgault, L. Doleris, J. Prinseau, A. Baglin et al., Systemic corticosteroid treatment and risk of infectious diseases]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, déc, vol.28, issue.12, p.84151, 2007.

A. Stuck, C. Minder, and F. Frey, Risk of Infectious Complications in Patients Taking Glucocorticosteroids, Clinical Infectious Diseases, vol.11, issue.6, p.95463, 1989.
DOI : 10.1093/clinids/11.6.954

T. Glück, B. Kiefmann, M. Grohmann, W. Falk, R. Straub et al., Immune status and risk for infection in patients receiving chronic immunosuppressive therapy, J Rheumatol. août, vol.32, issue.8, p.147380, 2005.

K. Shepard, A. Fishleder, F. Lucas, M. Goormastic, and R. Bukowski, Thrombotic thrombocytopenic purpura treated with plasma exchange or exchange transfusions, West J Med. avr, vol.154, issue.4, p.4103, 1991.

J. Blake-haskins, R. Lechleider, and R. Kreitman, Thrombotic Microangiopathy with Targeted Cancer Agents, Clinical Cancer Research, vol.17, issue.18, p.585866, 2011.
DOI : 10.1158/1078-0432.CCR-11-0804

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176977

L. Gall, J. Lemeshow, S. Saulnier, and F. , A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study, JAMA. 22 déc, vol.270, issue.24, p.295763, 1993.

J. Koessler, A. Kobsar, S. Kuhn, A. Koessler, P. Yilmaz et al., The effect of immunoadsorption with the Immusorba TR-350 column on coagulation compared to plasma exchange, Vox Sanguinis, vol.73, issue.1, p.4651, 2015.
DOI : 10.1111/vox.12191

S. Zöllner, E. Pablik, W. Druml, K. Derfler, A. Rees et al., Fibrinogen Reduction and Bleeding Complications in Plasma Exchange, Immunoadsorption and a Combination of the Two, Blood Purification, vol.38, issue.2, p.1606, 2014.
DOI : 10.1159/000367682

K. Schneider, Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy, Kidney Int févr, vol.64, p.615, 1998.

G. Stummvoll, Immunoadsorption (IAS) for systemic lupus erythematosus, Lupus, vol.17, issue.7, p.1159, 2011.
DOI : 10.1177/0961203310389487

G. Stummvoll, J. U. Derfler, K. Aringer, and M. , Immunoadsorption for systemic lupus erythematosus, Atherosclerosis Supplements, vol.10, issue.5, p.1103, 2009.
DOI : 10.1016/S1567-5688(09)71823-9

P. Chatainier, H. Bézanahar, J. Allard, G. Gondran, A. Cypierre et al., Syndrome catastrophique des anticorps anti-phospholides: intérêt de l'immunoadsorption. La Revue de médecine interne, pp.35-86, 2014.
DOI : 10.1016/j.revmed.2014.03.210

E. Jean, M. Brun, K. Harti, T. Allegre, J. Albanese et al., L'immunoadsorption: une technique complémentaire prometteuse dans le traitement du purpura thrombocytopénique thrombotique auto-immun réfractaire. 67e congrès de la Société nationale française de médecine interne?5, pp.6-7, 2013.
DOI : 10.1016/j.revmed.2013.03.135